General Information of the Compound
Compound ID
CP0514389
Compound Name
3-[[5-(2,3-dichloro-4-fluorophenyl)tetrazol-1-yl]methyl]pyridine
    Show/Hide
Structure
Formula
C13H8Cl2FN5
Molecular Weight
324.146
Canonical SMILES
Fc1ccc(-c2nnnn2Cc2cccnc2)c(Cl)c1Cl
    Show/Hide
InChI
InChI=1S/C13H8Cl2FN5/c14-11-9(3-4-10(16)12(11)15)13-18-19-20-21(13)7-8-2-1-5-17-6-8/h1-6H,7H2
    Show/Hide
InChIKey
PDNKNHYHFRICPY-UHFFFAOYSA-N
Physicochemical Property
logP
3.2293
Rotatable Bonds
3
Heavy Atom Count
21
Polar Areas
56.49
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11574070
SID: 16734345
ChEMBL ID
CHEMBL427223
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01449, P2X purinoceptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000094 1321N1 Homo sapiens (Human)  1
1
IC50 = 12.59 nM
   TI
   LI
   LO
   TS